portage biotech inc is a company based out of canada.
Company profile
Ticker
PRTG
Exchange
Website
CEO
Ian B. Walters
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Former names
BONTAN CORP INC, DEALCHECK COM INC
SEC CIK
PRTG stock data
Latest filings (excl ownership)
424B3
Prospectus supplement
8 Mar 24
6-K
Current report (foreign)
8 Mar 24
424B3
Prospectus supplement
6 Mar 24
6-K
Current report (foreign)
6 Mar 24
6-K
Company focused on adenosine platform clinical development
28 Feb 24
424B3
Prospectus supplement
28 Feb 24
6-K
Current report (foreign)
28 Feb 24
424B3
Prospectus supplement
18 Jan 24
6-K
Current report (foreign)
18 Jan 24
424B3
Prospectus supplement
4 Jan 24
Latest ownership filings
SC 13G
ARMISTICE CAPITAL, LLC
14 Feb 24
SC 13D/A
Portage Biotech Inc.
22 Jan 19
SC 13D/A
Portage Biotech Inc.
22 Jan 19
4/A
Biohaven Pharmaceutical Holding Co Ltd.
25 Jan 18
4
Biohaven Pharmaceutical Holding Co Ltd.
24 Jan 18
4/A
Biohaven Pharmaceutical Holding Co Ltd.
11 Jan 18
SC 13D
Portage Biotech Inc.
10 Jan 18
4
Biohaven Pharmaceutical Holding Co Ltd.
9 Jan 18
SC 13D/A
Portage Biotech Inc.
9 Jan 18
SC 13D/A
Portage Biotech Inc.
9 Jan 18
Financial summary
Quarter (USD) | Mar 23 | Mar 22 | Mar 21 | Mar 20 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Mar 23 | Mar 22 | Mar 21 | Mar 20 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Institutional ownership, Q2 2023
2.0% owned by funds/institutions
13F holders | Current |
---|---|
Total holders | 21 |
Opened positions | 9 |
Closed positions | 2 |
Increased positions | 2 |
Reduced positions | 2 |
13F shares | Current |
---|---|
Total value | 1.19 bn |
Total shares | 356.57 k |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
Lakeview Capital Partners | 213.40 k | $745.83 mm |
BLK Blackrock | 33.11 k | $115.72 mm |
Citadel Advisors | 18.75 k | $64.14 mm |
Dimensional Fund Advisors | 17.02 k | $58.19 mm |
Ieq Capital | 16.65 k | $58.19 mm |
Sigma Planning | 11.51 k | $40.22 mm |
Renaissance Technologies | 10.70 k | $37.00 k |
Advisor Partners Ii | 10.10 k | $35.30 mm |
Tower Research Capital | 6.43 k | $22.47 mm |
BCS Barclays | 5.66 k | $20.00 k |
News
12 Health Care Stocks Moving In Monday's After-Market Session
25 Mar 24
Why FactSet Research Shares Are Trading Lower By Around 5%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
21 Mar 24
Why Peraso Shares Are Trading Lower By Over 23%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
19 Mar 24
Why Fusion Pharmaceuticals Shares Are Trading Higher By Around 95%; Here Are 20 Stocks Moving Premarket
19 Mar 24
Why Clover Health Investments Shares Are Trading Higher By 11%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
13 Mar 24